JP2006526613A5 - - Google Patents

Download PDF

Info

Publication number
JP2006526613A5
JP2006526613A5 JP2006508431A JP2006508431A JP2006526613A5 JP 2006526613 A5 JP2006526613 A5 JP 2006526613A5 JP 2006508431 A JP2006508431 A JP 2006508431A JP 2006508431 A JP2006508431 A JP 2006508431A JP 2006526613 A5 JP2006526613 A5 JP 2006526613A5
Authority
JP
Japan
Prior art keywords
amino
propyl
aminopyridin
phenyl
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006508431A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006526613A (ja
Filing date
Publication date
Priority claimed from GBGB0312832.9A external-priority patent/GB0312832D0/en
Application filed filed Critical
Publication of JP2006526613A publication Critical patent/JP2006526613A/ja
Publication of JP2006526613A5 publication Critical patent/JP2006526613A5/ja
Withdrawn legal-status Critical Current

Links

JP2006508431A 2003-06-04 2004-06-01 β２−アドレナリン受容体アゴニストとしての２−（６−アミノ−ピリジン−３−イル）−２−ヒドロキシエチルアミン誘導体 Withdrawn JP2006526613A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0312832.9A GB0312832D0 (en) 2003-06-04 2003-06-04 2-amino-pyridine derivatives useful for the treatment of diseases
PCT/IB2004/001850 WO2004108676A1 (en) 2003-06-04 2004-06-01 2-(6-amino-pyridin-3-yl)-2-hydroxyethylamine derivatives as beta 2-adrenoceptors agonists

Publications (2)

Publication Number Publication Date
JP2006526613A JP2006526613A (ja) 2006-11-24
JP2006526613A5 true JP2006526613A5 (https=) 2007-06-14

Family

ID=9959308

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006508431A Withdrawn JP2006526613A (ja) 2003-06-04 2004-06-01 β２−アドレナリン受容体アゴニストとしての２−（６−アミノ−ピリジン−３−イル）−２−ヒドロキシエチルアミン誘導体

Country Status (18)

Country Link
EP (1) EP1633715B1 (https=)
JP (1) JP2006526613A (https=)
AR (1) AR044475A1 (https=)
AT (1) ATE372321T1 (https=)
BR (1) BRPI0410946A (https=)
CA (1) CA2527788A1 (https=)
CL (1) CL2004001366A1 (https=)
DE (1) DE602004008773T2 (https=)
ES (1) ES2291882T3 (https=)
GB (1) GB0312832D0 (https=)
GT (1) GT200400116A (https=)
MX (1) MXPA05012840A (https=)
NL (1) NL1026329C2 (https=)
PA (1) PA8604301A1 (https=)
PE (1) PE20050628A1 (https=)
TW (1) TW200524603A (https=)
UY (1) UY28339A1 (https=)
WO (1) WO2004108676A1 (https=)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0411056D0 (en) 2004-05-18 2004-06-23 Novartis Ag Organic compounds
AR049384A1 (es) 2004-05-24 2006-07-26 Glaxo Group Ltd Derivados de purina
UA87854C2 (en) 2004-06-07 2009-08-25 Мерк Энд Ко., Инк. N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
US7829712B2 (en) 2004-09-20 2010-11-09 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase
AR051091A1 (es) 2004-09-20 2006-12-20 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa
CA2580857A1 (en) 2004-09-20 2006-09-28 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
EP1807085B1 (en) 2004-09-20 2013-08-21 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
CA2580762A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as therapeutic agents
AU2005286648A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
EP2289510A1 (en) 2004-09-20 2011-03-02 Xenon Pharmaceuticals Inc. Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
GT200500281A (es) 2004-10-22 2006-04-24 Novartis Ag Compuestos organicos.
GB0424284D0 (en) 2004-11-02 2004-12-01 Novartis Ag Organic compounds
GB0426164D0 (en) 2004-11-29 2004-12-29 Novartis Ag Organic compounds
AU2006343359A1 (en) 2005-06-03 2007-11-15 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
BRPI0614290A2 (pt) 2005-08-08 2011-03-22 Argenta Discovery Ltd derivados de biciclo [ 2.2.1 ] hept-7-ilamina e seus usos
GB0516313D0 (en) 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
RU2421464C2 (ru) 2005-10-21 2011-06-20 Новартис Аг Человеческие антитела к il-13 и их терапевтическое применение
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
EP2322525B1 (en) 2006-04-21 2013-09-18 Novartis AG Purine derivatives for use as adenosin A2A receptor agonists
PL2035004T3 (pl) * 2006-06-09 2013-01-31 Parion Sciences Inc Podstawione fenylem pirazynoiloguanidynowe blokery kanału sodowego o aktywności beta-agonistycznej
EP2077262A4 (en) 2006-10-23 2011-12-28 Takeda Pharmaceutical IMINOPYRIDINE DERIVATIVE AND USE THEREOF
DE602008005140D1 (de) 2007-05-07 2011-04-07 Novartis Ag Organische verbindungen
MX2010006421A (es) 2007-12-10 2010-06-25 Novartis Ag Compuestos organicos.
MX2010007604A (es) 2008-01-11 2010-08-02 Novartis Ag Pirimidinas como inhibidores de cinasa.
US8481569B2 (en) 2008-04-23 2013-07-09 Takeda Pharmaceutical Company Limited Iminopyridine derivatives and use thereof
JP2011522860A (ja) 2008-06-10 2011-08-04 ノバルティス アーゲー 上皮性ナトリウムチャネルブロッカーとしてのピラジン誘導体
US8236786B2 (en) 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
DE102008049675A1 (de) 2008-09-30 2010-04-01 Markus Dr. Heinrich Verfahren zur Herstellung von 3-Aminobiphenylen
ES2442343T3 (es) 2008-12-30 2014-02-11 Pulmagen Therapeutics (Inflammation) Limited Compuestos de sulfonamida para el tratamiento de trastornos respiratorios
WO2010150014A1 (en) 2009-06-24 2010-12-29 Pulmagen Therapeutics (Inflammation) Limited 5r- 5 -deuterated glitazones for respiratory disease treatment
MX2012004792A (es) 2009-10-22 2013-02-01 Vertex Pharma Composiciones para el tratamiento de fibrosis quistica y otras enfermedades cronicas.
GB0918924D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Azaindole derivatives
GB0918923D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Aminothiazole derivatives
GB0918922D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Aminopyridine derivatives
WO2011098746A1 (en) 2010-02-09 2011-08-18 Pulmagen Therapeutics (Inflammation) Limited Crystalline acid addition salts of ( 5r) -enanti0mer of pioglitazone
GB201002243D0 (en) 2010-02-10 2010-03-31 Argenta Therapeutics Ltd Respiratory disease treatment
GB201002224D0 (en) 2010-02-10 2010-03-31 Argenta Therapeutics Ltd Respiratory disease treatment
US8247436B2 (en) 2010-03-19 2012-08-21 Novartis Ag Pyridine and pyrazine derivative for the treatment of CF
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
US8637516B2 (en) 2010-09-09 2014-01-28 Irm Llc Compounds and compositions as TRK inhibitors
US8372845B2 (en) 2010-09-17 2013-02-12 Novartis Ag Pyrazine derivatives as enac blockers
WO2012116217A1 (en) 2011-02-25 2012-08-30 Irm Llc Compounds and compositions as trk inhibitors
US8883819B2 (en) 2011-09-01 2014-11-11 Irm Llc Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
WO2013038381A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine/pyrazine amide derivatives
CN103946221B (zh) 2011-09-16 2016-08-03 诺华股份有限公司 用于治疗囊性纤维化的杂环化合物
US9056867B2 (en) 2011-09-16 2015-06-16 Novartis Ag N-substituted heterocyclyl carboxamides
WO2013038378A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine amide derivatives
WO2013038373A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine amide derivatives
US8809340B2 (en) 2012-03-19 2014-08-19 Novartis Ag Crystalline form
US9073921B2 (en) 2013-03-01 2015-07-07 Novartis Ag Salt forms of bicyclic heterocyclic derivatives
EP3134397A1 (en) 2014-04-24 2017-03-01 Novartis AG Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
KR20160141856A (ko) 2014-04-24 2016-12-09 노파르티스 아게 포스파티딜이노시톨 3-키나제 억제제로서의 피라진 유도체
KR20160145780A (ko) 2014-04-24 2016-12-20 노파르티스 아게 포스파티딜이노시톨 3-키나제 억제제로서의 아미노 피리딘 유도체
WO2020250116A1 (en) 2019-06-10 2020-12-17 Novartis Ag Pyridine and pyrazine derivative for the treatment of cf, copd, and bronchiectasis
PE20220346A1 (es) 2019-08-28 2022-03-14 Novartis Ag Derivados de 1,3-fenil heteroarilo sustituidos y su uso en el tratamiento de enfermedades

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4358455A (en) * 1980-12-23 1982-11-09 Merck & Co., Inc. Aralkylamindethanol heterocyclic compounds
CA2220399A1 (en) * 1995-05-10 1996-11-14 Pfizer Inc. .beta.-adrenergic agonists
EP1078924B1 (en) * 1999-07-23 2004-10-20 Pfizer Products Inc. Intermediates and a process for producing beta-adrenergic receptor agonists
TWI249515B (en) * 2001-11-13 2006-02-21 Theravance Inc Aryl aniline beta2 adrenergic receptor agonists
GB0217225D0 (en) * 2002-07-25 2002-09-04 Glaxo Group Ltd Medicinal compounds
EP1556034B1 (en) * 2002-10-11 2008-04-16 Pfizer Limited Indole derivatives as beta-2 agonists

Similar Documents

Publication Publication Date Title
JP2006526613A5 (https=)
JP2006511596A5 (https=)
ES2291882T3 (es) Derivados de 2-(6-amino-piridin-3-il)-2-hidroxietilamina como agonistas de adrenoceptores beta 2.
CA2499314A1 (en) Indole derivatives as beta-2 agonists
CA2553789A1 (en) Sulfonamide derivatives for the treatment of diseases
JP5254961B2 (ja) ベータアゴニスト活性を有するフェニル置換ピラジノイルグアニジンナトリウムチャネル遮断薬
ES2314395T3 (es) Derivados de (2-hidroxi-2-(4-hidroxi-3-hidroximetilfenil)-etilamino)-propil)fenilo como agonistas beta 2.
SI3097086T1 (en) (2S) -N - ((1S) -1-cyano-2-phenylethyl) -1,4-oxazepane-2-carboxamides as the dipeptidyl
US7268147B2 (en) Compounds useful for the treatment of diseases
US20080207689A1 (en) Formamide Derivatives For The Treatment of Diseases
RU2008136553A (ru) Производные бензотиазола в качестве агонистов бета2 адренорецептора
JP2008512470A5 (https=)
JP2007529499A5 (https=)
JP4054366B2 (ja) 疾患の治療のために有用な化合物
CN1942432A (zh) 作为β－2－激动剂的苯乙醇胺衍生物
CA2539070A1 (en) Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient
RU2012143978A (ru) Замещенный пиримидин в качестве антагониста рецептора простагландина d2
WO2009034432A2 (en) Novel compounds active as muscarinic receptor antagonists
MXPA05003105A (es) Compuestos de amonio cuaternario.
JP4819770B2 (ja) アドレナリン受容体として有用なホルムアミド誘導体
JP2008056680A5 (https=)
CN1934104A (zh) 用于治疗疾病的化合物
HK1096379A1 (zh) 用於治疗疾病的磺酰胺衍生物
HK1089097A (en) '(2-hydroxy-2-(4-hydroxy-3-hydroxymethylphenyl)-ethylamino)-propyl!phenyl derivatives as beta2 agonists
HK1101389A (en) Formamide derivatives useful as adrenoceptor